BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17580311)

  • 1. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events.
    Buratti E; Dhir A; Lewandowska MA; Baralle FE
    Nucleic Acids Res; 2007; 35(13):4369-83. PubMed ID: 17580311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intronic splicing code: multiple factors involved in ATM pseudoexon definition.
    Dhir A; Buratti E; van Santen MA; Lührmann R; Baralle FE
    EMBO J; 2010 Feb; 29(4):749-60. PubMed ID: 20094034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional studies on the ATM intronic splicing processing element.
    Lewandowska MA; Stuani C; Parvizpur A; Baralle FE; Pagani F
    Nucleic Acids Res; 2005; 33(13):4007-15. PubMed ID: 16030351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a.
    Coutinho G; Xie J; Du L; Brusco A; Krainer AR; Gatti RA
    Hum Mutat; 2005 Feb; 25(2):118-24. PubMed ID: 15643608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO).
    Cavalieri S; Pozzi E; Gatti RA; Brusco A
    Eur J Hum Genet; 2013 Jul; 21(7):774-8. PubMed ID: 23211698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM.
    Pastor T; Talotti G; Lewandowska MA; Pagani F
    Nucleic Acids Res; 2009 Nov; 37(21):7258-67. PubMed ID: 19773425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
    Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing.
    Pastor T; Pagani F
    PLoS One; 2011; 6(8):e23349. PubMed ID: 21858080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
    J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.
    Nakamura K; Du L; Tunuguntla R; Fike F; Cavalieri S; Morio T; Mizutani S; Brusco A; Gatti RA
    Hum Mutat; 2012 Jan; 33(1):198-208. PubMed ID: 22006793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
    Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
    Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.
    Lee M; Roos P; Sharma N; Atalar M; Evans TA; Pellicore MJ; Davis E; Lam AN; Stanley SE; Khalil SE; Solomon GM; Walker D; Raraigh KS; Vecchio-Pagan B; Armanios M; Cutting GR
    Am J Hum Genet; 2017 May; 100(5):751-765. PubMed ID: 28475858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
    Petersen USS; Doktor TK; Andresen BS
    Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mutations in the ATM gene and clinical data of 25 AT patients.
    Demuth I; Dutrannoy V; Marques W; Neitzel H; Schindler D; Dimova PS; Chrzanowska KH; Bojinova V; Gregorek H; Graul-Neumann LM; von Moers A; Schulze I; Nicke M; Bora E; Cankaya T; Oláh É; Kiss C; Bessenyei B; Szakszon K; Gruber-Sedlmayr U; Kroisel PM; Sodia S; Goecke TO; Dörk T; Digweed M; Sperling K; de Sá J; Lourenco CM; Varon R
    Neurogenetics; 2011 Nov; 12(4):273-82. PubMed ID: 21965147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.
    Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F
    Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.
    Teraoka SN; Telatar M; Becker-Catania S; Liang T; Onengüt S; Tolun A; Chessa L; Sanal O; Bernatowska E; Gatti RA; Concannon P
    Am J Hum Genet; 1999 Jun; 64(6):1617-31. PubMed ID: 10330348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.
    Sanz DJ; Hollywood JA; Scallan MF; Harrison PT
    PLoS One; 2017; 12(9):e0184009. PubMed ID: 28863137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
    Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
    Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UG repeats/TDP-43 interactions near 5' splice sites exert unpredictable effects on splicing modulation.
    Passoni M; De Conti L; Baralle M; Buratti E
    J Mol Biol; 2012 Jan; 415(1):46-60. PubMed ID: 22100394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.